Clinical outcomes of HPV-positive non-oropharyngeal squamous cell carcinoma: analysis of the NCDB

被引：0
|
作者：
Ko, H. [1 ]
Sacotte, R. [2 ]
Yu, M. [1 ]
Chen, S. [1 ]
Wieland, A. [1 ]
Witek, M. [1 ]
机构：
[1] Univ Wisconsin, Sch Med & Publ H, Human Oncol, Madison, WI USA
[2] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
来源：
RADIOTHERAPY AND ONCOLOGY | 2017年 / 122卷
关键词：
D O I：
10.1016/S0167-8140(17)30241-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-107
引用
收藏
页码：51 / 52
页数：2
相关论文
共 50 条
  • [41] Prospective assessment of multiple HPV-positive oropharyngeal squamous cell carcinomas
    Faden, Daniel L.
    O'Boyle, Connor J.
    Lin, Derrick T.
    Deschler, Daniel G.
    Emerick, Kevin S.
    Varvares, Mark A.
    Faquin, William C.
    Sadow, Peter M.
    Richmon, Jeremy D.
    ORAL ONCOLOGY, 2021, 117
  • [42] From HPV-positive towards HPV-driven oropharyngeal squamous cell carcinomas
    Boscolo-Rizzo, Paolo
    Pawlita, Michael
    Holzinger, Dana
    CANCER TREATMENT REVIEWS, 2016, 42 : 24 - 29
  • [43] Systemic inflammation is an independent predictive marker of clinical outcomes in mucosal squamous cell carcinoma of the head and neck in oropharyngeal and non-oropharyngeal patients
    Charles, Kellie A.
    Harris, Benjamin D. W.
    Haddad, Carol R.
    Clarke, Stephen J.
    Guminski, Alex
    Stevens, Mark
    Dodds, Tristan
    Gill, Anthony J.
    Back, Michael
    Veivers, David
    Eade, Thomas
    BMC CANCER, 2016, 16
  • [44] Systemic inflammation is an independent predictive marker of clinical outcomes in mucosal squamous cell carcinoma of the head and neck in oropharyngeal and non-oropharyngeal patients
    Kellie A. Charles
    Benjamin D. W. Harris
    Carol R. Haddad
    Stephen J. Clarke
    Alex Guminski
    Mark Stevens
    Tristan Dodds
    Anthony J. Gill
    Michael Back
    David Veivers
    Thomas Eade
    BMC Cancer, 16
  • [45] Analysis of Expression and Regulation of AKR1C2 in HPV-Positive and -Negative Oropharyngeal Squamous Cell Carcinoma
    Ziogas, Maria
    Siefer, Oliver
    Wuerdemann, Nora
    Balaji, Harini
    Gross, Elena
    Drebber, Uta
    Klussmann, Jens Peter
    Huebbers, Christian U.
    CANCERS, 2024, 16 (17)
  • [46] Mapping the landscape of HPV integration and characterising virus and host genome interactions in HPV-positive oropharyngeal squamous cell carcinoma
    Xu, Shengming
    Shi, Chaoji
    Zhou, Rong
    Han, Yong
    Li, NianNian
    Qu, Chuxiang
    Xia, Ronghui
    Zhang, Chunye
    Hu, Yuhua
    Tian, Zhen
    Liu, Shuli
    Wang, Lizhen
    Li, Jiang
    Zhang, Zhiyuan
    CLINICAL AND TRANSLATIONAL MEDICINE, 2024, 14 (01):
  • [47] Prevalence and distribution of cervical lymph node metastases in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma
    Bauwens, Laurence
    Baltres, Aline
    Fiani, Danny-Joe
    Zrounba, Philippe
    Buiret, Guillaume
    Fleury, Bertrand
    Benzerdjeb, Nazim
    Gregoire, Vincent
    RADIOTHERAPY AND ONCOLOGY, 2021, 157 : 122 - 129
  • [48] The Role of Human Chorionic Gonadotropin Beta (hCGβ) in HPV-Positive and HPV-Negative Oropharyngeal Squamous Cell Carcinoma
    Sjoblom, Anni
    Carpen, Timo
    Stenman, Ulf-Hakan
    Jouhi, Lauri
    Haglund, Caj
    Syrjanen, Stina
    Mattila, Petri
    Makitie, Antti
    Hagstrom, Jaana
    CANCERS, 2022, 14 (12)
  • [49] Genomic instability in HPV-positive oropharyngeal squamous cell carcinoma: The role of integration sites in treatment response
    Haridevamuthu, B.
    ORAL ONCOLOGY, 2024, 155
  • [50] Management of Recurrent and Metastatic HPV-Positive Oropharyngeal Squamous Cell Carcinoma after Transoral Robotic Surgery
    Sims, John R.
    Van Abel, Kathryn
    Martin, Eliot J.
    Lohse, Christine M.
    Price, Daniel L.
    Olsen, Kerry D.
    Moore, Eric J.
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2017, 157 (01) : 69 - 76
12345